• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Self-Help App for Depression in People With Intellectual Disabilities: A Randomized Clinical Trial

byJayden BerdugoandSimon Pan
October 16, 2025
in Chronic Disease, Imaging and Intervention, Psychiatry
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this randomized clinical trial, the use of a smartphone self-help app was associated with increased self-esteem and quality of life, and a decrease in depressive symptoms in individuals with intellectual disabilities (IDs). 

Evidence Rating Level: 1 (Excellent) 

Intellectual disabilities (IDs) affect a small portion of the population, and around 34% of these individuals also experience mental health issues, especially depression, anxiety, and psychosis. These conditions are underdiagnosed due to diagnostic overshadowing and reliance on self-reporting. Although cognitive behavioural therapy is helpful, access to mental health care in this population is limited. One possible effective treatment alternative is smartphone-based interventions. This randomized clinical trial tested a self-help app called Happy, designed to reduce depression and boost self-esteem in people with IDs. This study aimed to assess the extent to which the app was accepted and whether it could improve mental well-being. 99 participants were randomized 1:1 to the intervention group (n=50) or the waiting list control group (n=49). Among the included participants, 93 completed the postintervention assessment. The intervention group had a significantly greater reduction in depressive symptoms compared to the control group (F1, 97 = 7.52, P = .007) with a medium effect size (np2=0.072). The intervention group also showed improvements in quality of life (QoL) (F1,97 = 5.09; ηp2 = 0.050 [small to medium effect]) (P = .03) and self-esteem (F1,97 = 17.94; ηp2 = 0.156 [large effect]) (P < .001). Overall, this randomized clinical trial found that this self-help was effective in reducing depressive symptoms and improving self-esteem and quality of life in individuals with IDs. 

Click here to read this study in JAMA Network Open

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

RELATED REPORTS

2 Minute Medicine Rewind October 13, 2025

Higher tetrahydrocannabinol exposure may be associated with unfavorable mental health outcomes

Early screening for emotional and cognitive issues may improve psychiatric outcomes for stroke patients

Tags: depressionintellectual disabilitymobile applicationself-esteemself-help
Previous Post

A Hybrid Chatbot to Promote Pneumococcal Vaccination Among Older Adults: A Randomized Clinical Trial

Next Post

Rate of incident dementia and care needs among older adults with new traumatic brain injury: a population-based cohort study

RelatedReports

Weekly Rewinds

2 Minute Medicine Rewind October 13, 2025

October 13, 2025
Parental cannabis use increasing, cigarette use decreasing
Psychiatry

Higher tetrahydrocannabinol exposure may be associated with unfavorable mental health outcomes

August 27, 2025
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Neurology

Early screening for emotional and cognitive issues may improve psychiatric outcomes for stroke patients

June 20, 2025
Vegetarian diet may lower incidence of colorectal cancer
Psychiatry

Calorie restriction and low-fat diets may reduce depression in individuals with higher cardiometabolic risk

May 20, 2025
Next Post
Unpaid caregivers of older adults experience emotional, physical, and financial difficulty

Rate of incident dementia and care needs among older adults with new traumatic brain injury: a population-based cohort study

Using HEART score to risk stratify patients with chest pain is safe but underutilized in the ED

2 Minute Medicine Rewind October 20, 2025

Bisphosphonate use and risk of atypical femur fractures

Effect of sitagliptin vs. placebo on bone mineralization in women with type 2 diabetes: the SLowDOWN (SitagLiptin in Diabetes for Osteoporosis in WomeN) randomized clinical trial

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes
  • New York confirms first locally acquired chikungunya case in six years
  • Smartphone-Based Muscle Relaxation for Migraine in the Emergency Department
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.